NGF activates similar intracellular signaling pathways in vascular smooth muscle cells as PDGF-BB but elicits different biological responses

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 4, 1999, Pages 1041-1050

  Kraemer, Rosemary ^a   Nguyen, Hiep ^a   March, Keith L ^b   Hempstead, Barbara ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Migration; Proliferation; Signal transduction; Smooth muscle cells; trk

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; GROWTH FACTOR; INOSITOL PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; PHOSPHOLIPASE C; SOMATOMEDIN; SOMATOMEDIN C; WORTMANNIN;

ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME ACTIVITY; LIGAND BINDING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

EID: 0032921162     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.4.1041     Document Type: Article

References (69)

1. Ross R. Pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Majack RA, Grieshaber NA, Cook CL, Weiser MCM, McFall RC, Grieshaber SS, Reidy MA, Reilly CF. Smooth muscle cells isolated from the neointima after vascular injury exhibit altered responses to platelet-derived growth factor and other stimuli. J Cell Plivsiol. 1996;167: 106-112.
3. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111:2149-2158.
4. Ross R, Masuda J, Raines E, Gown A, Kutsuda S, Sasahara M, Malden L, Masuko H, Sato H. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science. 1990;248:1009-1012.
5. Cercek B, Fishbein MC, Forrester JS, Helfant RH, Fagin JA. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res. 1990;66:1755-1760.
6. Khorsandi MJ, Fagin JA, Giannella-Neto D, Forrester JS, Cercek B. Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation. J Clin Invest. 1992;90:1926-1931.
7. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG, Ross R. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest. 1994;93:1266-1274.
8. Mii S, Khalil RA, Morgan KG, Ware JA, Kent KC. Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells. Am J Physiol. 1996;39:H142-H150.
9. Bornfeldt KE, Graves LM, Raines EW, Igarashi Y, Wayman G, Yamamura S, Yatomi Y, Sidhu JS, Krebs EG, Hakomori S, Ross R. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J Cell Biol. 1995;130:193-206.
10. Ranganna K, Joshi T, Yatsu FM. Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995;15:2273-2283.
11. Bornfeldt KE. Intracellular signaling in arterial smooth muscle migration versus proliferation. Trends Cardiovasc Med. 1996;6:143-151.
12. Higaki M, Sakaue H, Ogawa W, Kasuga M, Shimokado K. Phosphatidylinositol 3 kinase-independent signal transduction pathway for platelet-derived growth factor-induced chemotaxis. J Biol Chem. 1996;271: 29342-29346.
13. Clyman RI, Peters KG, Chen YQ, Escobedo J, Williams LT, Ives HE, Wilson E. Phospholipase-C gamma activation, phosphatidylinositol hydrolysis, and calcium mobilization are not required for FGF receptor-mediated chemotaxis. Cell Adhes Commun. 1994;1:333-342.
14. Donovan MJ, Miranda RC, Kraemer R, Mccaffrey TA, Tessarollo L, Mahadeo D, Sharif S, Kaplan DR, Tsoulfas P, Parada L, Toran-Allerand D, Hajjar DP, Hempstead BL. Neurotrophin and neurotrophin receptors in vascular smooth muscle cells: regulation of expression in response to injury. Am J Pathol. 1995;147:309-324.
15. Barde Y-A. Trophic factors and neuronal survival. Neuron. 1989;2: 1525-1534.
16. Levi-Montalcini R. The nerve growth factor: 35 years later. Science. 1987;237:1154-1162.
17. Chao M. Neurotrophin receptors: a window into neuronal differentiation. Neuron. 1992;9:583-593.
18. Chao MV, Hempstead BL. p75 and trk: a two-receptor system. Trends Neurosci. 1995;18:321-326.
19. Soltoff S, Rabin S, J., Cantley L, Kaplan DR. Nerve growth factor promotes the activation of phosphatidylinositol 3-kinase and its association with the trk tyrosine kinase. J Biol Chem. 1992;267:17472-17477.
20. Stephens RM, Loeb DM, Copeland TD, Pawson T, Greene LA, Kaplan DR. Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses. Neuron. 1994;12: 691-705.
21. Segal RA, Bhattacharyya A, Rua LA, Alberta JA, Stephens RM, Kaplan DR, Stiles CD. Differential utilization of Trk autophosphorylation sites. J Biol Chem. 1996;271:20175-20181.
22. Greene LA, Kaplan DR. Early events in neurotrophin signalling via Trk and p75 receptors. Curr Opin Neurobiol. 1995;5:579-587.
23. Pauly RR, Bilato C, Sollott SJ, Monticone R, Kelly PT, Lakatta EG, Crow MT. Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration. Circulation. 1995;91: 1107-1115.
24. Deleted in proof.
25. Hempstead BL, Rabin SJ, Kaplan L, Reid S, Parada LF, Kaplan DR. Overexpression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation. Neuron. 1992;9:883-896.
26. Huber LJ, Chao MV. A potential interaction of p75 and trk A NGF receptors revealed by affinity crosslinking and immunoprecipitation. J Neurosci Res. 1995;40:557-563.
27. Kraemer R, Pomerantz K, Joseph-Silverstein J, Hajjar D. Induction of basic FGF mRNA and protein synthesis in smooth muscle cells by cholesterol-enrichment and 25-hydroxy-cholesterol. J Biol Chem. 1993; 268:8040-8045.
28. Hempstead BL, Birge RB, Fajardo JE, Glassman R, Mahadeo D, Kraemer R, Hanafusa H. Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor and epidermal growth factor pathways. Mol Cell Biol. 1994;14:1964-1971.
29. prototrk. Neuron. 1992;9:1053-1065.
30. Teng KK, Landers H, Mahȧdeo D, Hanafusa H, Hempstead BL, Birge RB. Sustained activation of a Ras/MAP kinase cascade in PC12 mediated by v-Crk in response to EGF and NGF. J Biol Chem. 1995;270: 20677-20685.
31. Whitman M, Kaplan DR, Schaffhausen B, Cantly L, Roberts TM. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature. 1985;315:239-242.
32. Kaplan DR, Morrison DK, Wong G, McCormick F, Williams LT. PDGF b-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex. Cell. 1990;61:125-133.
33. Arcaro A, Wymann MP. Wotmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-triphosphate in neutrophil responses. Biochem J. 1993;296:297-301.
34. Ui M, Okada T, Hazekj K, Hazeki O. Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci. 1995;20:303-307.
35. Yano H, Agatsuma T, Nakanishi S, Saitoh Y, Nonomura Y, Matsuda Y. Biochemical and pharmacological studies with KT7692 and LY294002 on the role of phosphatidylinositol 3-kinase in Fc epsilon RI-mediated signal transduction. Biochem J. 1995;312:145-150.
36. Bornfeldt KE, Campbell JS, Koyama H, Argast GM, Leslie CC, Raines EW, Krebs EG, Ross R. The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. J Clin Invest. 1997;100:875-885.
37. Grotendorst GR, Igarashi A, Larson R, Soma Y, Charette M. Differential binding, biological and biochemical actions of recombinant PDGF AA, AB, and BB molecules on connective tissue cells. J Cell Physiol. 1991; 149:235-243.
38. Fantl WJ, Johnson DE, Williams LT. Signalling by receptor tyrosine kinases. Annu Rev Biochem. 1993;62:453-481.
39. Pazin MJ, Williams LT. Triggering signaling cascades by receptor tyrosine kinases. Trends Biochem Sci. 1992;17:374-378.
40. Wary KK, Mainiero F, Isakoff SJ, Marcanotonio EE, Giancotti FG, Marcantonio EE. The adaptor protein She couples a class of integrins to the control of cell cycle progression. Cell. 1996;87:733-743.
41. Folkman J, Moscona A. Role of cell shape in growth control. Nature. 1978;273:345-349.
42. Hansen LK, Mooney DJ, Vacanti JP, Ingber DE. Integrin binding and cell spreading on extracellular matrix act at different points in the cell cycle to promote hepatocyte growth. Mol Biol Cell. 1994;5:967-975.
43. Fang F, Orend G, Watanabe N, Hunter T, Ruoslahti E. Dependence of cyclinE-CDK2 kinase activity on cell anchorage. Science. 1996;271: 499-502.
44. Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell. 1996;87:1069-1078.
45. Joneson T, White MA, Wigler MH, Bar-Sagi D. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science. 1996;271:810-812.
46. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993;268:14553-14556.
47. Nobes CD, Hall A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia and filopodia. Cell. 1995;81:53-62.
48. Symons M. Rho family GTPases: the cytoskeleton and beyond. Trends Biochem Sci. 1996;21:178-181.
49. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 1992;70:389-399.
50. Toker A, Cantley LC. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature. 1997;387:673-676.
51. Chou MM, Blenis J. The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Curr Opin Cell Biol. 1995;7: 806-814.
52. Carpenter CL, Cantley LC. Phosphoinositide kinases. Curr Opin Cell Biol. 1996;8:153-158.
53. Fantl WJ, Escobedo JA, Martin GA, Turck CW, Del Rosario M, McCormick F, Williams LT. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell. 1992;69:413-423.
54. Roche S, Koegl M, Courtneidge SA. The phosphatidylinositol 3 kinase alpha is required for DNA synthesis induced by some, but not all growth factors. Proc Natl Acad Sci U S A. 1994;91:9185-9189.
55. Roche S, McGlade J, Jones M, Gish GD, Pawson T, Courtneidge SA. Requirement of phospholipase C gamma, the tyrosine phosphatase Syp and the adaptor proteins Sch and Nck for PDGF-induced DNA synthesis: evidence for the existence of Ras-dependent and Ras-independent pathways. EMBO J. 1996;15:4940-4948.
56. Weiss RH, Yabes AP. Mitogenic inhibition by phorbol esters is associated with decreased phosphatidylinositol-3 kinase activation. Am J Physiol. 1996;39:C619-C627.
57. Khalil RA, Morgan KG. PKC-mediated redistribution of mitogen-activated protein kinase during smooth muscle cell activation. Am J Physiol. 1993;265:C406-C411.
58. Lenormand P, Sardet C, Pages G, L'Allemain G, Brunet A, Pouyssegur J. Growth factors induce nuclear translocation of MAP kinases (p42 MAPK and p44 MAPK) but not of their activator MAP kinase kinase (p45 MAPK) in fibroblasts. J Cell Biol. 1993;122:1079-1088.
59. Maraldi NM, Zini N, Ognibene A, Martelli AM, Barbieri M, Mazzotti G, Manzoli FA. Immunocytochemical detection of the intracellular variations of phosphatidylinositol 4,5-biphosphate amount associated with changes of activity and amount of phospholipase C beta 1 in cells exposed to mitogenic or differentiating agonists. Biol Cell. 1995;83:201-210.
60. Seely BL, Reichart DR, Staubs PA, Jhun BH, Hsu D, Maegawa H, Milarski KL, Saltiel AR, Olefsky JM. Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein. J Biol Chem. 1995;270:19151-19157.
61. 2 hydrolysis and regulation of phospholipase C isozymes. Curr Opin Cell Biol. 1995;7:183-189.
62. Spiegal S, Foster D, Kolesnick R. Signal transduction through lipid second messengers. Curr Opin Cell Biol. 1996;8:159-167.
63. Pang L, Sawada T, Decker SJ, Saltiel AR. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem. 1995;270:13585-13588.
64. Baltensperger K, Kozma LM, Jaspers SR, Czech MP. Regulation by insulin of phosphatidylinositol 3′-kinase bound to alpha-and beta-isoforms of p85 regulatory subunit. J Biol Chem. 1994;269:28937-28946.
65. Reif K, Gout I, Waterfield MD, Cantrell DA. Divergent regulation of phosphatidylinositol 3-kinase alpha and p85 beta isoforms upon T cell activation. J Biol Chem. 1993;268:10780-10788.
66. Hu P, Schlessinger J. Direct association of the p110 beta phosphatidylinositol 3 kinase with p85 is mediated by an N terminal fragment of p110 beta. Mol Cell Biol. 1994;14:2577-2583.
67. Volinia S, Hiles I, Ormondroyd E, Nizetic D, Antonacci R, Rocchi M, Waterfield MD. Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110 alpha (PI3CA) gene. Genomics. 1994;24:472-477.
68. Andrea JE, Walsh MP. Protein kinase C of smooth muscle. Hypertension. 1992;20:585-595.
69. Leng L, Du B, Consigli S, Mccaffrey TA. Translocation of protein kinase C-delta by PDGF in vascular smooth muscle cells: inhibition by TGF-beta1. Artery. 1996;22:140-154.